Elosulfase alfa API Manufacturers
compare suppliers & get competitive offers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Elosulfase alfa is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Elosulfase alfa or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Elosulfase alfa API 9025-60-9?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Elosulfase alfa. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Elosulfase alfa
- Synonyms:
- N-acetylgalactosamine-6-sulfatase
- Cas Number:
- 9025-60-9
- DrugBank number:
- DB09051
- Unique Ingredient Identifier:
- ODJ69JZG85
About Elosulfase alfa
You can find a short description about Elosulfase alfa here. Elosulfase alfa is a synthetic version of the enzyme N-acetylgalactosamine-6-sulfatase. It was approved by the FDA in 2014 for the treatment of Morquio syndrome. Elosulfase alfa was developed by BioMarin Pharmaceutical Inc. and is marketed under the brand Vimizim™. The recommended dose is 2 mg per kg given intravenously over a minimum range of to hours, based on infusion volume, once every week.
You can ask the supplier for more technical information about the product.
